<SEC-DOCUMENT>0001564590-22-019287.txt : 20220510
<SEC-HEADER>0001564590-22-019287.hdr.sgml : 20220510
<ACCEPTANCE-DATETIME>20220510161820
ACCESSION NUMBER:		0001564590-22-019287
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220510
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220510
DATE AS OF CHANGE:		20220510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viracta Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001061027
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943295878
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51531
		FILM NUMBER:		22909915

	BUSINESS ADDRESS:	
		STREET 1:		2533 S COAST HWY 101
		STREET 2:		SUITE 210
		CITY:			CARDIFF
		STATE:			CA
		ZIP:			92007
		BUSINESS PHONE:		858-400-8470

	MAIL ADDRESS:	
		STREET 1:		2533 S COAST HWY 101
		STREET 2:		SUITE 210
		CITY:			CARDIFF
		STATE:			CA
		ZIP:			92007

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MOSAIC PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19980709

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUNESIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19980501
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>virx-8k_20220510.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-05-10T19:34:53.5977037+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : bfbbe050dcd24a91b87df5cc98ef772d -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:virx="http://viracta.com/20220510" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
virx-8k_20220510.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001061027_20220510_20220510">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0001061027_20220510_20220510">0001061027</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="virx-20220510.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001061027_20220510_20220510">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001061027</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-05-10</xbrli:startDate>
					<xbrli:endDate>2022-05-10</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="text-align:center;border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WASHINGTON, D.C. 20549</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001061027_20220510_20220510">8-K</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT</p>
<p style="text-align:center;margin-bottom:6pt;margin-top:9pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-right:0.37%;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported): <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001061027_20220510_20220510" format="ixt:datemonthdayyearen">May 10, 2022</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:5pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0001061027_20220510_20220510">VIRACTA THERAPEUTICS, INC.</ix:nonNumeric></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of Registrant as Specified in Its Charter)</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001061027_20220510_20220510" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0001061027_20220510_20220510">000-51531</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001061027_20220510_20220510">94-3295878</ix:nonNumeric></p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or Other Jurisdiction<br />of Incorporation)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission File Number)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer<br />Identification No.)</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:20%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:20%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine1" contextRef="C_0001061027_20220510_20220510">2533 S. Coast Hwy. 101</ix:nonNumeric>, <ix:nonNumeric id="F_000010" name="dei:EntityAddressAddressLine2" contextRef="C_0001061027_20220510_20220510">Suite 210</ix:nonNumeric></p></td>
<td colspan="2" valign="top" style="padding-left:0pt;padding-Right:0pt;width:59%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000011" name="dei:EntityAddressCityOrTown" contextRef="C_0001061027_20220510_20220510">Cardiff</ix:nonNumeric>, <ix:nonNumeric id="F_000012" name="dei:EntityAddressStateOrProvince" contextRef="C_0001061027_20220510_20220510" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000013" name="dei:EntityAddressPostalZipCode" contextRef="C_0001061027_20220510_20220510">92007</ix:nonNumeric></p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of Principal Executive Offices)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:9pt;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0.37%;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s Telephone Number, Including Area Code:<span style="font-weight:normal;"> </span><ix:nonNumeric id="F_000014" name="dei:CityAreaCode" contextRef="C_0001061027_20220510_20220510">(858)</ix:nonNumeric><span style="font-weight:normal;"> </span><ix:nonNumeric id="F_000015" name="dei:LocalPhoneNumber" contextRef="C_0001061027_20220510_20220510">400-8470</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former Name or Former Address, if Changed Since Last Report)</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:WrittenCommunications" contextRef="C_0001061027_20220510_20220510" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:95.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td>
</tr>
<tr>
<td valign="top" style="width:4.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:SolicitingMaterial" contextRef="C_0001061027_20220510_20220510" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:95.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
<tr>
<td valign="top" style="width:4.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementTenderOffer" contextRef="C_0001061027_20220510_20220510" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:95.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
<tr>
<td valign="top" style="width:4.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0001061027_20220510_20220510" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:95.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act:</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;width:38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;width:15%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Trading<br />Symbol(s)</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;width:45%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:Security12bTitle" contextRef="C_0001061027_20220510_20220510">Common Stock,  par value $0.0001 per share</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:15%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:TradingSymbol" contextRef="C_0001061027_20220510_20220510">VIRX</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:45%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:SecurityExchangeName" contextRef="C_0001061027_20220510_20220510" format="ixt-sec:exchnameen">The NASDAQ Stock Market LLC</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter). </p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company <span style="font-family:Segoe UI Symbol;color:#000000;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001061027_20220510_20220510" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:MS Gothic;color:#000000;">&#9744;</span></p>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 2.02 Results of Operations and Financial Condition.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On May 10, 2022, Viracta Therapeutics, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for the fiscal quarter ended March 31, 2022. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All of the information furnished in this Item 2.02 and the press release attached hereto as Exhibit 99.1 shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01 Financial Statements and Exhibits.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(d) Exhibits</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="width:91%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:8%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="width:91%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr>
<td valign="top" style="width:8%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:91%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:91%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="d333155dex991.htm"><span style="text-decoration:underline;">Press Release, dated May 10, 2022</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:91%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:9pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</p>
<p style="margin-bottom:9pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:46%;">
<p style="margin-bottom:4pt;margin-top:4pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Viracta Therapeutics, Inc.</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-top:4pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-top:4pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">May 10, 2022</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-top:4pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: </p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:46%; border-bottom:solid 0.75pt #000000;">
<p style="margin-top:4pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Daniel Chevallard</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:46%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:9pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Daniel Chevallard<br />Chief Operating Officer and Chief Financial Officer </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d333155dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head><META content="text/html; charset=utf-8"></META></head><body style="font-size:10pt;font-family:Arial;color:black;">
<div style="width:100%;margin-left:10pt">
  <div align="right"><b>Exhibit 99.1</b></div>
</div>
<div style="width:100%;margin-left:10pt">
  <p style="text-align:center"><b>Viracta Therapeutics Reports First Quarter 2022
    Financial Results and Recent Updates</b></p>
</div>
<div style="width:100%;margin-left:10pt;"><div style="margin:0;margin-top:16pt;"><p style="text-align: center;"><i>Continued global expansion of NAVAL-1, the pivotal trial of Nana-val for the treatment of Epstein-Barr virus-positive (EBV<sup>+</sup>) lymphoma; update on the initial cohort(s) that have advanced into Stage 2 anticipated in the second half of 2022</i></p><p style="text-align: center;"><i>Preliminary safety and efficacy data for the Phase 1b/2 trial of Nana-val in advanced EBV<sup>+</sup> solid tumors anticipated in the second half of 2022</i></p><p style="text-align: center;"><i>Cash balance of $92.2 million as of March 31, 2022; projected cash runway into mid-2024 </i></p><p>SAN DIEGO, May 10, 2022 /PRNewswire/ -- Viracta Therapeutics, Inc.
(Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today reported financial results for the first quarter of 2022 and provided an update on recent corporate progress.</p><p>&#34;We have made encouraging progress in both clinical programs with our all-oral drug product candidate, Nana-val, which are advancing towards potential key catalysts in the second half of the year,&#34; said Ivor Royston, M.D., President and Chief Executive Officer of Viracta. &#34;Since the first patient was dosed in January, our Phase 1b/2 trial of Nana-val in patients with advanced EBV-positive solid tumors has proceeded nicely and we anticipate reporting preliminary safety and efficacy data later this year. In addition, we are pleased to have expanded the clinical reach of NAVAL-1 beyond North America into Europe as well as Asia, and anticipate having an update on cohorts
advancing into Stage 2 of the trial later this year.&#34;</p><p><b>First Quarter 2022 and Recent Highlights</b></p><p><b><i>Clinical</i></b></p><ul type="disc"><li><b>Continued global expansion and enrollment into NAVAL-1, the pivotal trial of Nana-val (nanatinostat and valganciclovir) for the treatment of patients with relapsed/refractory EBV<sup>+</sup> lymphoma. </b>NAVAL-1 employs a Simon two-stage design where patients are initially enrolled into six cohorts based on lymphoma subtype in Stage 1. If a pre-specified activity threshold is reached, additional patients will be enrolled in Stage 2. Lymphoma subtypes demonstrating promising activity in Stage 2 may be further expanded. If successful, the Company believes NAVAL-1 could potentially support multiple new drug application filings across various EBV<sup>+ </sup>lymphoma subtypes. Clinical sites are open across the globe,
including in the U.S., Canada, Europe, and Asia. The Company anticipates providing an update on the initial cohort(s) that may advance into Stage 2 of the trial in the second half of the year.</li><li><b>Dosed first patient in the Phase 1b/2 trial of Nana-val in patients with EBV<sup>+</sup> recurrent or metastatic nasopharyngeal carcinoma (R/M NPC) and other EBV<sup>+</sup> solid tumors. </b>Enrollment continues in the Phase 1b dose escalation part of the study, which is designed to evaluate safety and determine the recommended Phase 2 dose (RP2D) of Nana-val in patients with EBV<sup>+</sup> R/M NPC. In Phase 2, up to 60 patients with EBV<sup>+</sup> R/M NPC will be randomized to receive Nana-val at the RP2D with or without pembrolizumab to evaluate safety and preliminary efficacy. Additionally, patients with other EBV<sup>+</sup> solid tumors will be enrolled to receive Nana-val at
the RP2D in a Phase 1b dose expansion cohort. Viracta anticipates reporting preliminary Phase 1b safety and efficacy data from the trial in the second half of 2022.</li></ul><p><b><i>Corporate</i></b></p><ul type="disc"><li><b>Hosted key opinion leader webinar on Nana-val for the treatment of advanced EBV<sup>+</sup> solid tumors. </b>The webinar featured presentations from key opinion leader Ezra Cohen, MD, FRCPSC, FASCO (University of California, San Diego) and members of the Viracta management team. Topics discussed included the current treatment landscape and unmet medical need in NPC, the design of the Phase 1b/2 trial of Nana-val in advanced EBV<sup>+</sup> solid tumors, and preclinical data supporting the trial. A replay of the webinar is available here.</li></ul><p><b>Anticipated 2022 Milestones</b></p><ul type="disc"><li>Provide preliminary Phase 1b safety and efficacy data
from the Phase 1b/2 trial in advanced EBV<sup>+</sup> solid tumors: 2H 2022</li><li>Update on NAVAL-1 cohort(s) that may progress from Stage 1 to Stage 2: 2H 2022</li></ul><p><b>First Quarter 2022 Financial Results</b></p><ul type="disc"><li><b>Cash Position &#8211; </b>Cash and cash equivalents totaled approximately $92.2 million as of March 31, 2022, which Viracta expects will be sufficient to fund its operations into mid-2024, excluding any borrowing under its previously announced $50.0 million credit facility from Silicon Valley Bank and Oxford Finance.</li><li><b>Research and development expenses </b>&#8211; Research and development expenses were approximately $6.1 million for the three months ended March 31, 2022, compared to $4.0 million for the same period in 2021. The increase in research and development expenses for the three months ended March 31, 2022, was primarily due to
increases in costs incurred to support the initiation of the NAVAL-1 and solid tumor trials as well as an increase in headcount and non-cash share-based compensation.</li><li><b>Acquired in-process research and development </b>&#8211; For the three months ended March 31, 2021, the acquired in-process research and development included non-cash and non-recurring cost of $84.5 million associated with the estimated fair value of the in-process research and development projects acquired in the Sunesis asset acquisition with no alternative future use, which was charged to expense on the Sunesis merger date.</li><li><b>General and administrative expenses </b>&#8211; General and administrative expenses were approximately $4.3 million for the three months ended March 31, 2022, compared to $3.8 million for the same period in 2021. The increase was largely due to incremental costs associated with
being a publicly traded company including directors and officers&#39; insurance costs, and non-cash share-based compensation.</li><li><b>Gain on Royalty Purchase Agreement </b>&#8211; For the three months ended March 31, 2021, the gain was associated with upfront proceeds of $13.5 million recorded in connection with the multi-license milestone and royalty monetization transaction with XOMA (US) LLC.</li><li><b>Adjusted loss from operations</b>&#160;&#8211; There was not a comparative adjustment to loss from operations for the quarter ended March 31, 2022. Adjusted income from operations for the quarter ended March 31, 2021, excluding the non-recurring and non-cash operating expenses associated with the write-off of in-process research and development acquired in the merger (a non-GAAP measure) was $5.6 million, compared to an unadjusted loss from operations of $78.8
million.</li><li><b>Net loss </b>&#8211; Net loss was approximately $10.5 million, or $0.28 per share (basic and diluted) for the quarter ended March 31, 2022, compared to a net loss of $79.2 million or $5.22 per share for the same period in 2021.</li></ul><p><b>About Nana-val (Nanatinostat and Valganciclovir)</b></p><p>Nanatinostat is an orally available histone deacetylase (HDAC) inhibitor being developed by Viracta. Nanatinostat is selective for specific isoforms of Class I HDACs, which is key to inducing viral genes that are epigenetically silenced in EBV-associated malignancies. Nanatinostat is currently being investigated in combination with the antiviral agent valganciclovir as an all-oral combination therapy, Nana-val, in various subtypes of EBV-associated malignancies. Ongoing trials include a pivotal, global, multicenter, open-label Phase 2 basket trial in multiple subtypes of
relapsed/refractory EBV<sup>+ </sup>lymphoma (NAVAL-1) as well as a multinational Phase 1b/2 trial in patients with EBV<sup>+</sup> recurrent or metastatic nasopharyngeal carcinoma and other EBV<sup>+</sup> solid tumors.</p><p><b>About EBV-Associated Cancers</b></p><p>Approximately 90% of the world&#39;s adult population is infected with Epstein-Barr virus (EBV). Infections are commonly asymptomatic or associated with mononucleosis. Following infection, the virus remains latent in a small subset of lymphatic cells for the duration of the patient&#39;s life. Cells containing latent virus are increasingly susceptible to malignant transformation. Patients who are immunocompromised are at an increased risk of developing EBV<sup>+ </sup>lymphomas. EBV is estimated to be associated with approximately 2% of the global cancer burden and is also associated with a variety of solid tumors,
including nasopharyngeal carcinoma and gastric cancer.</p><p><b>About Viracta Therapeutics, Inc.</b></p><p>Viracta is a precision oncology company targeting virus-associated malignancies. Viracta&#39;s lead product candidate is an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir (collectively referred to as Nana-val). Nana-val is currently being evaluated in multiple ongoing clinical trials, including a pivotal, global, multicenter, open-label Phase 2 basket trial for the treatment of multiple subtypes of relapsed/refractory EBV<sup>+</sup> lymphoma (NAVAL-1), as well as a multinational Phase 1b/2 trial for the treatment of EBV<sup>+ </sup>recurrent or metastatic nasopharyngeal carcinoma and other EBV<sup>+</sup> solid tumors. Viracta is also pursuing the application of its inducible synthetic lethality approach
in other virus-related cancers.</p><p>For additional information please visit www.viracta.com.</p><p><b>Forward-Looking Statements </b></p><p>This communication contains &#34;forward-looking&#34; statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding: the details, timeline and expected progress for Viracta&#39;s ongoing trials and updates regarding the same; the significance of the Nana-val trial results, NAVAL-1 as a potential registration-enabling trial, the utility Viracta&#39;s therapeutic approach, the strength of Viracta&#39;s clinical dataset, the ability of Viracta to obtain one or more accelerated approvals, the timeline for further clinical program updates in the second half of 2022; Viracta&#39;s plans to provide updates on NAVAL-1 in the second half of 2022; expectations regarding the
Company&#39;s pipeline and potential products; Viracta&#39;s cash projections and the sufficiency its cash and cash equivalents to fund operations into 2024; the future availability of capital under Viracta&#39;s credit facility; the expected 2022 milestones and key upcoming events and their significance; and other statements that are not historical facts.  Risks and uncertainties related to Viracta that may cause actual results to differ materially from those expressed or implied in any forward-looking statement include, but are not limited to: Viracta&#39;s ability to successfully enroll patients in and complete its ongoing and planned clinical trials; Viracta&#39;s plans to develop and commercialize its product candidates, including all oral combinations of nanatinostat and valganciclovir; the timing of initiation of Viracta&#39;s planned clinical trials; the timing of the
availability of data from Viracta&#39;s clinical trials; previous preclinical and clinical results may not be predictive of future clinical results; the timing of any planned investigational new drug application or new drug application; Viracta&#39;s plans to research, develop and commercialize its current and future product candidates; the clinical utility, potential benefits and market acceptance of Viracta&#39;s product candidates; Viracta&#39;s ability to manufacture or supplying nanatinostat, valganciclovir and pembrolizumab for clinical testing; Viracta&#39;s ability to identify additional products or product candidates with significant commercial potential; developments and projections relating to Viracta&#39;s competitors and its industry; the impact of government laws and regulations; Viracta&#39;s ability to protect its intellectual property position; and Viracta&#39;s
estimates regarding future expenses, capital requirements and need for additional financing in the future.</p><p>These risks and uncertainties may be amplified by the COVID-19 pandemic, which has caused significant economic uncertainty. If any of these risks materialize or underlying assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the caption &#34;Risk Factors&#34; and elsewhere in Viracta&#39;s reports and other documents that Viracta has filed, or will file, with the SEC from time to time and available at www.sec.gov.</p><p>The forward-looking statements included in this communication are made only as of the date hereof. Viracta
assumes no obligation and does not intend to update these forward-looking statements, except as required by law or applicable regulation.</p><p><b>Investor Relations Contact:
<br /></b>Ashleigh Barreto
<br />Head of Investor Relations &amp; Corporate Communications
<br />Viracta Therapeutics, Inc.
<br />abarreto@viracta.com</p><p style="text-align: center;">Financials Attached</p><p> </p><div><div><table style="border-collapse: collapse; border: 1pt none black;" border="0" cellspacing="0" cellpadding="0"><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Viracta Therapeutics, Inc.</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6"
rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Selected Balance Sheet Highlights</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b><i>(in thousands)</i></b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style:
none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: middle; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>March 31,</b></font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: middle; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>December 31,</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2022</b></font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2021</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b><i>(Unaudited)</i></b></font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: top; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Cash and cash equivalents</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family:
Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">92,199</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">103,554</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: top; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Total assets</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt;
font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">98,387</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">108,552</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: top; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Total liabilities</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size:
8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">12,782</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">14,181</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: top; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Stockholders&#39; equity</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font
style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">85,605</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">94,371</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1" nowrap>
<br /></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Viracta Therapeutics, Inc.</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt;
font-family: Arial; color: black;"><b>Condensed Consolidated Statement of Operations and Comprehensive Loss</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b><i>(in thousands except share and per share data)</i></b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1" nowrap><p style="margin: 0px 0pt
0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b><i>(Unaudited)</i></b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1" nowrap>
<br /></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="5" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Three Months Ended March 31,</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2022</b></font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2021</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: top; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt;
font-family: Arial; color: black;">Operating expenses:</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Research and development</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family:
Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">6,096</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">4,024</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Acquired in-process research and development</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">&#8212;</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">84,478</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">General and administrative</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">4,336</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">3,840</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">Total operating expenses</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">10,432</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">92,342</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Gain on
Royalty Purchase Agreement</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">&#8212;</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">13,500</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family:
Arial; color: black;">Loss from operations</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(10,432)</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(78,842)</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Total other
expense</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(114)</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(389)</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">Net loss and comprehensive loss</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(10,546)</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font
style="font-size: 8pt; font-family: Arial; color: black;">(79,231)</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Net loss per share, basic and diluted</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(0.28)</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font
style="font-size: 8pt; font-family: Arial; color: black;">(5.22)</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Weighted-average common shares
<br />outstanding, basic and diluted</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 0.5pt 1pt 1pt; border-style: solid none none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 0.5pt 1pt 1pt; border-style: solid none none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">37,535,874</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 0.5pt 1pt 1pt; border-style: solid none none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 0.5pt 1pt 1pt; border-style: solid none none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">15,166,737</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: middle; text-align: center;" colspan="6" rowspan="1" nowrap>
<br /></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: middle; text-align: center;" colspan="6" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Viracta Therapeutics, Inc.</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: middle; text-align: center;" colspan="6" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt;
font-family: Arial; color: black;"><b>Reconciliation of GAAP Loss from Operations to Adjusted (Loss) Income from Operations</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: middle; text-align: center;" colspan="6" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b><i>(in thousands)</i></b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: middle; text-align: center;" colspan="6" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px;
font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b><i>(Unaudited)</i></b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: middle; text-align: center;" colspan="6" rowspan="1" nowrap>
<br /></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: middle; text-align: center;" colspan="4" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Three Months Ended March 31,</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2022</b></font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2021</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: top; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Loss from operations</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial;
color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(10,432)</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">(78,842)</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 18px; border-width: 1pt; border-style: none; border-color: black; vertical-align: middle; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Less: Acquired in-process research and development</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">-</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">84,478</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: middle;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">Adjusted (loss) income from operations</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(10,432)</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">5,636</font></font></p></td></tr></table></div></div><p> </p><p> </p>
<br /><br />
    <p><img src="d333155dlogo.jpg" title="viracta_therapeutics_inc_log.jpg" width="400" height="110"></p>
    <p>  </p></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>d333155dlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 d333155dlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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MDJ'2%B0S.4-B<I25T1@T1%1S@I/!&1IC@]0E)I:QPO_$ !P!  ,! 0$! 0$
M           &!P@%! ,! O_$ $41  $!!00&!P,)!P0#      $"  ,$!1$&
M$B$Q!T%187&!$Q0B-9&AP14RL1<C-D)B<G.RT5)4@I+A\/$6)-+B,Z*S_]H
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M4+M"#0^\-;1]_P#'LWFOSSLW_P".0OW*9;T(F^9M WT]AN87O:%=8EVN-HR
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MW5HLV\PPQG&=ANZWD+3HY#;*?XO$/AY-"B5#XQQSP%3"J&VPG?7XTI=GYM&
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MN7V\>E<U?K'=SN>?YBV6K?\ ?\1Q3^5+.GZLW[U+/OI>?N,:LB]8/_FX[O\
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MG^Z2_P#H+_RISO5H(KL3=BVA!UIQHG*TD!:"DG^),>-,@]CV/B6OU!6]IA#
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>0W;PI6]6G_JWCD6C,2Z.=QHB+UPUI=I7#;>+?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>virx-20220510.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-05-10T19:34:53.5977037+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : bfbbe050dcd24a91b87df5cc98ef772d -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:virx="http://viracta.com/20220510" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://viracta.com/20220510" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" namespace="http://xbrl.sec.gov/country/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" namespace="http://xbrl.sec.gov/currency/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" namespace="http://xbrl.sec.gov/exch/2022" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" namespace="http://xbrl.sec.gov/sic/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd" namespace="http://fasb.org/srt-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" namespace="http://fasb.org/srt-types/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" namespace="http://xbrl.sec.gov/stpr/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd" namespace="http://fasb.org/us-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" namespace="http://fasb.org/us-types/2022" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://viracta.com/20220510/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="virx-20220510_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="virx-20220510_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>virx-20220510_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-05-10T19:34:53.5977037+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : bfbbe050dcd24a91b87df5cc98ef772d -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>virx-20220510_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-05-10T19:34:53.5977037+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : bfbbe050dcd24a91b87df5cc98ef772d -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://viracta.com/20220510/role/TemplateLink" xlink:href="virx-20220510.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="virx-20220510.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140339419804632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 10,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VIRACTA THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001061027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3295878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2533 S. Coast Hwy. 101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cardiff<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">400-8470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock,  par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VIRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>virx-8k_20220510_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="virx-20220510.xsd" xlink:type="simple"/>
    <context id="C_0001061027_20220510_20220510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001061027</identifier>
        </entity>
        <period>
            <startDate>2022-05-10</startDate>
            <endDate>2022-05-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0001061027_20220510_20220510" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0001061027_20220510_20220510" id="F_000004">0001061027</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0001061027_20220510_20220510" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0001061027_20220510_20220510" id="F_000002">2022-05-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0001061027_20220510_20220510" id="F_000003">VIRACTA THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001061027_20220510_20220510" id="F_000007">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0001061027_20220510_20220510" id="F_000006">000-51531</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001061027_20220510_20220510" id="F_000008">94-3295878</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001061027_20220510_20220510" id="F_000009">2533 S. Coast Hwy. 101</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0001061027_20220510_20220510" id="F_000010">Suite 210</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0001061027_20220510_20220510" id="F_000011">Cardiff</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001061027_20220510_20220510" id="F_000012">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001061027_20220510_20220510" id="F_000013">92007</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001061027_20220510_20220510" id="F_000014">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001061027_20220510_20220510" id="F_000015">400-8470</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0001061027_20220510_20220510" id="F_000016">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0001061027_20220510_20220510" id="F_000017">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0001061027_20220510_20220510" id="F_000018">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0001061027_20220510_20220510" id="F_000019">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0001061027_20220510_20220510" id="F_000020">Common Stock,  par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001061027_20220510_20220510" id="F_000021">VIRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001061027_20220510_20220510" id="F_000022">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001061027_20220510_20220510" id="F_000005">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M(0BK_3OV?F%D7K[7KJ2!M^3R<,,9I)R] 'Z/I31O"_NJ7/W3,?D74$L#!!0
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MX_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0
M   ( #R"JE0'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ /(*J5+(5%MON    *P(  !$
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M;',O+G)E;'-02P$"% ,4    "  \@JI4'#AEZC\!   \ @  #P
M    @ %G$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ /(*J5"0>FZ*M
M    ^ $  !H              ( !TQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ /(*J5&60>9(9 0  SP,  !,
M ( !N!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @   A0
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="virx-8k_20220510.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="virx-8k_20220510.htm">virx-8k_20220510.htm</File>
    <File>d333155dex991.htm</File>
    <File>virx-20220510.xsd</File>
    <File>virx-20220510_lab.xml</File>
    <File>virx-20220510_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "virx-8k_20220510.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "virx-8k_20220510.htm"
     ]
    },
    "labelLink": {
     "local": [
      "virx-20220510_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "virx-20220510_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "virx-20220510.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "virx",
   "nsuri": "http://viracta.com/20220510",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "virx-8k_20220510.htm",
      "contextRef": "C_0001061027_20220510_20220510",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "virx-8k_20220510.htm",
      "contextRef": "C_0001061027_20220510_20220510",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001564590-22-019287-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-22-019287-xbrl.zip
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M/^0S<&7H8OOM[F_BU9N+'19<PM9S5_JEO?)YA2&!09MLE@$.4T)F4*\VDPE
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M)6F:7--?N!+RH&MA U>4,'%U%2<%J_#18:?=*2D-@ LJ%P,_0*H%T]!*P._
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MTKO ZD:^WZ=BO>J*OIKMBKYK=D5KC=S&J8H#/*U:4-I7U1A*.V$H_0 U0$1
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M91BE(F PA %8(5/?F3?(5CXNQH5IU5LN)K.*\$#MD"HJX!2,BFFD%2.IA=.
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MP(P?S+I,*:CF;&1(VHGM*[R)^RZ;2=>;0C ^YQ&*+W;$=J]67-5%Q=7R;%^
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M,#(R,#4Q,"YX<V102P$"% ,4    "  \@JI46X+G@B@'  #P2P  %0
M        @ '('P  =FER>"TR,#(R,#4Q,%]L86(N>&UL4$L! A0#%     @
M/(*J5/NM=3(#!0  ""T  !4              ( !(R<  '9I<G@M,C R,C U
M,3!?<')E+GAM;%!+ 0(4 Q0    ( #R"JE1IJKE'XA   ,^2   4
M      "  5DL  !V:7)X+3AK7S(P,C(P-3$P+FAT;5!+!08     !0 % $8!
(  !M/0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
